1. Home
  2. AORT vs DKL Comparison

AORT vs DKL Comparison

Compare AORT & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AORT
  • DKL
  • Stock Information
  • Founded
  • AORT 1984
  • DKL 2012
  • Country
  • AORT United States
  • DKL United States
  • Employees
  • AORT N/A
  • DKL N/A
  • Industry
  • AORT Medical/Dental Instruments
  • DKL Natural Gas Distribution
  • Sector
  • AORT Health Care
  • DKL Energy
  • Exchange
  • AORT Nasdaq
  • DKL Nasdaq
  • Market Cap
  • AORT 2.1B
  • DKL 2.4B
  • IPO Year
  • AORT 1993
  • DKL N/A
  • Fundamental
  • Price
  • AORT $39.96
  • DKL $45.84
  • Analyst Decision
  • AORT Strong Buy
  • DKL Buy
  • Analyst Count
  • AORT 6
  • DKL 4
  • Target Price
  • AORT $40.63
  • DKL $44.25
  • AVG Volume (30 Days)
  • AORT 407.7K
  • DKL 58.6K
  • Earning Date
  • AORT 11-06-2025
  • DKL 11-05-2025
  • Dividend Yield
  • AORT N/A
  • DKL 9.76%
  • EPS Growth
  • AORT N/A
  • DKL 1.28
  • EPS
  • AORT N/A
  • DKL 2.96
  • Revenue
  • AORT $405,037,000.00
  • DKL $920,213,000.00
  • Revenue This Year
  • AORT $14.99
  • DKL $15.67
  • Revenue Next Year
  • AORT $10.80
  • DKL N/A
  • P/E Ratio
  • AORT N/A
  • DKL $15.46
  • Revenue Growth
  • AORT 7.44
  • DKL N/A
  • 52 Week Low
  • AORT $21.97
  • DKL $34.59
  • 52 Week High
  • AORT $45.07
  • DKL $48.00
  • Technical
  • Relative Strength Index (RSI)
  • AORT 45.52
  • DKL 67.07
  • Support Level
  • AORT $39.27
  • DKL $44.70
  • Resistance Level
  • AORT $44.47
  • DKL $44.20
  • Average True Range (ATR)
  • AORT 1.23
  • DKL 0.85
  • MACD
  • AORT -0.85
  • DKL 0.26
  • Stochastic Oscillator
  • AORT 13.27
  • DKL 98.23

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests

Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.

Share on Social Networks: